I agree something does not add up, if the Contract 2019 EBITDA contribution is still around the $15m forecast at acquisition it implies the Pacific + Nova EBITDA is forecasted to be $40m, or $5m less than FY2018.
More likely the Contract Power 2019 EBITDA contribution was overestimated as the last 3 months of FY2018 the EBITDA attributed to Contract was $1.725m, or only $6.9m on an annualised basis. Either way the management will need to find some more synergies to make the Contract Power acquisition EPS accretive as they claimed it would be.
- Forums
- ASX - By Stock
- PEA
- Ann: FY18 Results Presentation
Ann: FY18 Results Presentation, page-3
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PEA (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.09 |
Change
0.005(0.46%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
$1.09 | $1.09 | $1.09 | $80.13K | 73.80K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 20979 | $1.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.09 | 93741 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 42510 | 0.620 |
1 | 20000 | 0.580 |
1 | 5000 | 0.550 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.630 | 12637 | 1 |
0.640 | 36649 | 2 |
0.645 | 7751 | 1 |
0.650 | 20578 | 2 |
0.655 | 8750 | 1 |
Last trade - 13.41pm 24/09/2019 (20 minute delay) ? |
Featured News
PEA (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online